Lab
Ameri Labpro INC
Ameri Labpro INC was paid $100K by Medicaid between Aug 2023 and Nov 2024, across 63 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 29% of everything it billed.
33Billing provider infoAMERI LABPRO INC
TORRANCE, CA 90503
TORRANCE, CA 90503
33aNPI1568169266assigned 02/13/2023
33bProvider typeClinical Medical Laboratory
28Total paid$100K
24GClaims20,380
24DCodes billed63
24AFirst – last monthAug 2023 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#326 of 561
Median peer was paid$222K
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 4,002 | $36K | |
| 2024incomplete | 16,378 | $63K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 29% | 2,269 | 1,704 | $29K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.8% | 322 | 322 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.5% | 545 | 543 | $4K |
| 82746 | 4.2% | 432 | 432 | $4K | |
| 82607 | 4.0% | 429 | 429 | $4K | |
| 80061 | Lipid panel | 3.5% | 536 | 534 | $3K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 3.2% | 264 | 264 | $3K |
| 83970 | 3.1% | 182 | 182 | $3K | |
| 80053 | Comprehensive metabolic panel | 3.0% | 499 | 488 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.4% | 349 | 348 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 680 | 666 | $2K |
| 82670 | 2.1% | 171 | 171 | $2K |
51 more codes
| 83735 | 1.9% | 457 | $2K | |
| 82627 | 1.7% | 171 | $2K | |
| 84402 | 1.6% | 157 | $2K | |
| 84144 | 1.6% | 171 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.5% | 75 | $2K |
| 84481 | 1.4% | 219 | $1K | |
| 87486 | 1.3% | 1,210 | $1K | |
| 87581 | 1.3% | 1,210 | $1K | |
| 84550 | 1.2% | 444 | $1K | |
| 87498 | 1.2% | 1,036 | $1K | |
| 87640 | 1.1% | 1,220 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 162 | $1K |
| 87653 | <1% | 1,052 | $963.70 | |
| 84153 | <1% | 85 | $914.12 | |
| 87481 | <1% | 1,051 | $914.11 | |
| 87500 | <1% | 1,050 | $914.09 | |
| 83003 | <1% | 147 | $903.66 | |
| 84410 | <1% | 20 | $902.40 | |
| 83002 | <1% | 122 | $875.07 | |
| 84403 | <1% | 37 | $786.31 | |
| 81001 | <1% | 272 | $669.45 | |
| 84439 | <1% | 253 | $606.57 | |
| 82043 | <1% | 234 | $596.46 | |
| 84270 | <1% | 34 | $589.98 | |
| 87150 | <1% | 154 | $545.68 | |
| 84146 | <1% | 47 | $472.43 | |
| 82728 | <1% | 138 | $423.04 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 131 | $364.50 |
| 83540 | <1% | 109 | $300.16 | |
| 82150 | <1% | 149 | $283.80 | |
| 84460 | <1% | 129 | $229.17 | |
| 82570 | <1% | 59 | $224.01 | |
| 84450 | <1% | 129 | $221.70 | |
| 84075 | <1% | 129 | $210.83 | |
| 82247 | <1% | 129 | $207.63 | |
| 82040 | <1% | 129 | $204.39 | |
| 82565 | <1% | 129 | $204.04 | |
| 82310 | <1% | 129 | $194.77 | |
| 84295 | <1% | 129 | $172.58 | |
| 84132 | <1% | 129 | $169.81 | |
| 82533 | <1% | 25 | $161.99 | |
| 84520 | <1% | 130 | $151.60 | |
| 84155 | <1% | 129 | $151.58 | |
| 83550 | <1% | 118 | $122.53 | |
| 82977 | <1% | 113 | $106.68 | |
| 87541 | <1% | 151 | $93.34 | |
| 83037 | <1% | 24 | $81.39 | |
| 82947 | <1% | 116 | $53.42 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 29 | $50.80 |
| 86140 | <1% | 14 | $13.65 | |
| 85652 | <1% | 16 | $9.52 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSARGSYAN, KARINE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Life Medical Practitioners | San Diego, CA | $484K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.